Study: Live H5N1 virus vaccines effective

Sep 12, 2006

U.S. scientists say live, weakened versions of differing strains of avian flu viruses have offered protection when tested in mice and ferrets.

Researchers say their findings are encouraging because they demonstrate the ability to create a vaccine based on one particular strain of the H5N1 flu virus that could potentially protect against different emerging H5N1 flu strains.

"If an influenza pandemic were imminent or under way, we would need a vaccine that could stimulate immunity quickly, preferably with a single dose," said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. "The encouraging findings of this study suggest vaccines based on live, but weakened, versions of the H5N1 avian influenza virus may quickly stimulate protective immunity.

"We are further exploring this live, attenuated vaccine strategy as one of several tools that we hope to have available in the event of an influenza pandemic," he added.

Senior investigator Dr. Kanta Subbarao and co-chief investigator Dr. Brian Murphy explain the research in the Sept. 12 issue of PLoS Medicine.

Copyright 2006 by United Press International

Explore further: Seals and sea lions likely brought tuberculosis to the Americas, new research shows

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Neonatal vitamin K refusal tied to nonimmunization

11 minutes ago

(HealthDay)—While neonatal vitamin K refusal is rare, parents who refuse vitamin K are less likely to immunize their child, according to a study published online Aug. 18 in Pediatrics.

Uranium exposure tied to lupus

21 minutes ago

(HealthDay)—High uranium exposure is associated with systemic lupus erythematosus (SLE), according to a study published online Aug. 7 in Arthritis & Rheumatology.

User comments : 0